NOV 08, 2017 12:00 PM PST
The Opioid Crisis and other Novel Psychoactive Substances (NPS): Forensic Toxicological Perspectives
Presented at the Clinical Diagnostics & Research 2017 Virtual Event
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
1 1 17

Speakers:
  • Sr. Vice President, Quality Assurance Laboratory Director & Forensic Toxicologist, NMS Labs
    Biography
      Robert A. Middleberg is the Laboratory Director and Senior VP of Laboratory Operations and Quality Assurance at NMS Labs. He is a Fellow of the American Board of Forensic Toxicology and a Diplomate of the American Board of Clinical Chemistry, and currently sits as a Board Director of the ABFT and recently completed his tenure on the Board of Directors of ABCC. He served as Toxicology Section Chair within AAFS, and was Chair of the Scientific Working Group in Toxicology from its beginning to its end in 2014. He currently is a member of CAP's Toxicology Resource Committee, and sits on the Toxicology Subcommittee within the NIST OSAC. In 2013, Dr. Middleberg was awarded the Rolla N. Harger Award by the Toxicology section of the American Academy of Forensic Sciences for his contributions to the field and profession of forensic toxicology.

    Abstract:

    Novel psychoactive substances (NPS) emerged in the United States around 2000.  Initially, synthetic cannabinoids and stimulants prevailed.  Now, designer opioids, benzodiazepines and others have appeared.  As a result of pain management, in addition to common drug abusers, a whole new set of individuals in desperate search for pain medications have become abusers of the NPS version of designer opioids helping spur the current opioid crisis in the United States.  The adverse effects of NPS have become significant public health and public safety concerns.  Adverse effects from these substances range from psychosis to death with abusers often committing crimes or injuring themselves.  From a forensic toxicological concern, deaths from NPS are now commonplace.  The landscape of these compounds changes frequently, making it difficult for toxicology laboratories to stay relevant.  The analytical tools required are costly and laboratories need to constantly update the scope of compounds within the assay.  The history of NPS, their associated effects and the breadth of the problem from social and scientific perspectives will be addressed along with future outlooks for this class of substances that have become a costly part of the drug use and abuse scenes in respect to lives lost and eradication.


    Show Resources
    Loading Comments...